Bruker Corporation BRKR
NASDAQ · United States · Health Technology
$64.75+0.24 (+0.37%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | 0.49 | 0.38 | +27.3% | $838.50M | -1.8% | -18.4%$64.31→$52.47 |
| Q1 2026 | 2026-05-06 | 0.31 | 0.23 | +34.8% | — | — | +15.0%$38.01→$43.73 |
| Q4 2025 | 2026-02-12 | 0.59 | 0.65 | -9.2% | — | — | -14.0%$42.43→$36.51 |
| Q3 2025 | 2025-11-03 | 0.45 | 0.32 | +40.6% | — | — | +3.7%$38.94→$40.38 |
| Q2 2025 | 2025-08-04 | 0.32 | 0.42 | -23.8% | — | — | — |
| Q4 2024 | 2025-02-13 | 0.76 | 0.74 | +2.7% | — | — | — |
| Q3 2024 | 2024-11-05 | 0.60 | 0.60 | 0.0% | — | — | — |
| Q4 2023 | 2024-02-13 | 0.70 | 0.66 | +6.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.